Product Information
AZITHROMYCIN I.V. 500 MG VIAL is a generic product labeled by Eugia US LLC, priced at $3.5270 per EA under NDC 55150017410. Its NADAC has been published 70 times since Dec 18, 2024.
FDA first approved this application on Jun 19, 2015. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the Azithromycin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Eugia US LLCNDC
55150017410
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
4/23/2025
Active Ingredients
AZITHROMYCIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203294FDA Approved
6/19/2015
TE Code
AP
On Market Since
6/19/2015
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN I.V. 500 MG VIAL has been published 70 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5270 per EA |
|---|---|
| All-time high | $3.5270 (Apr 15, 2026) |
| All-time low | $3.5270 (Dec 18, 2024) |
| 52-week high | $3.5270 |
| 52-week low | $3.5270 |
| Median price | $3.5270 |
| Average price | $3.5270 |
| Largest weekly change | 0.0% (Dec 25, 2024) |
| Weeks tracked | 70 |
| Tracking since | Dec 18, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AZITHROMYCIN I.V. 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN I.V. 500 MG VIAL, manufactured by Eugia US LLC, is $3.5270 per EA (NDC 55150017410), effective Apr 15, 2026.
How has the price of AZITHROMYCIN I.V. 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN I.V. 500 MG VIAL has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN I.V. 500 MG VIAL?
Since Dec 18, 2024, the NADAC for AZITHROMYCIN I.V. 500 MG VIAL has ranged from a low of $3.5270 (Dec 18, 2024) to a high of $3.5270 (Apr 15, 2026), with a median of $3.5270 per EA.
Are there cheaper alternatives to AZITHROMYCIN I.V. 500 MG VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AZITHROMYCIN I.V. 500 MG VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures AZITHROMYCIN I.V. 500 MG VIAL?
AZITHROMYCIN I.V. 500 MG VIAL (NDC 55150017410) is labeled by Eugia US LLC, and CMS classifies it as a generic product.